Search Results 51-60 of 17306 for Hypocalcemia

  1. Denosumab-bnht (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium in the blood)—Should not be given to patients with this condition. Back to top. Proper Use. A doctor or other trained health ...

  2. Denosumab-mobz (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium in the blood)—Should not be given to patients with this condition. Back to top. Proper Use. A doctor or other trained health ...

  3. Calciphylaxis - Symptoms and causes - Mayo Clinic

    Calciphylaxis treatments include various medicines, procedures and surgery. Treatment can help prevent blood clots and infections, reduce calcium buildups, heal ...

  4. Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic

    Researchers found that the ratio of 25(OH)D-to-24,25(OH)2D is necessary to estimate the calculation of vitamin D 24-hydroxylase enzyme activity to confirm ...

  5. Romosozumab-aqqg (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium levels in the blood) or; Stroke within the last year—Should not be used in patients with these conditions. Kidney disease, severe ...

  6. Denosumab-qbde (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium in the blood)—Should not be given to patients with this condition. Back to top. Proper Use. A doctor or other trained health ...

  7. Using fluorescence angiography to predict and prevent hypoparathyroidism after thyroid surgery - Mayo Clinic

    However, this objective assessment also helps to identify patients who may be at risk of short-term hypocalcemia, and allows us to initiate treatment sooner.

  8. Denosumab-bmwo (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium in the blood)—Should not be given to patients with this condition. Back to top. Proper Use. A doctor or other trained health ...

  9. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  10. Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Metabolic Control and Symptoms Among Adults With Hypoparathyroidism - Mayo Clinic

    The diagnosis of hypoparathyroidism is established based on hypocalcemia in the setting of inappropriately low serum PTH levels. During the Week -3 ...